| Cefmenoxime therapy of serious bacterial infections. | |||||||||||
Abstract | |||||||||||
| The efficacy and safety of cefmenoxime was evaluated in 50 patients with serious bacterial infections. These included 26 pneumonias, 18 urinary tract infections, 2 soft tissue infections, 2 bacteremias, 1 renal abscess, and 1 peritonitis. A satisfactory clinical response was seen in 47 patients (94%). Eosinophilia and thrombocytosis were seen in several patients but were generally mild and transient. | |||||||||||
Publication details | |||||||||||
| |||||||||||